Esperion Therapeutics ESPR Common Stock Shares Outstanding
Common Stock Shares Outstanding at other companies
Other financials
Where this comes from
Reported directly by Esperion Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.
The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Esperion Therapeutics's common stock shares outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Esperion Therapeutics's common stock shares outstanding?
- Esperion Therapeutics (ESPR) reported common stock shares outstanding of $4.75M in Q1 2026.
- How has Esperion Therapeutics's common stock shares outstanding changed year-over-year?
- Esperion Therapeutics's common stock shares outstanding increased by 39500.0% year-over-year, from $12K to $4.75M.
- What is the long-term trend for Esperion Therapeutics's common stock shares outstanding?
- Over 5 years (2020 to 2025), Esperion Therapeutics's common stock shares outstanding has grown at a -15.4% compound annual growth rate (CAGR), from $18.42M to $8M.
- What does common stock shares outstanding mean?
- This represents the total number of common shares held by all shareholders, including institutional investors and insiders. It serves as the denominator for calculating earnings per share and is a key indicator of potential equity dilution. Changes in this figure reflect share repurchases, new issuances, or conversion of convertible securities.